-

Shareholder Alert: Robbins LLP Reminds Investors eHealth, Inc. (EHTH) Sued for Misleading Shareholders

SAN DIEGO & SANTA CLARA, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of eHealth, Inc. (NASDAQ: EHTH) filed a class action complaint against the Company for alleged violations of the Securities Exchange Act of 1934 between March 19, 2018 and April 7, 2020. eHealth provides private health insurance exchange services to individuals, families, and small businesses in the United States and China.

If you suffered a loss as a result of eHealth's misconduct, click here.

eHealth, Inc. (EHTH) Accused of Misleading Shareholders

According to the complaint, on January 22, 2019, eHealth issued a press release announcing its full year 2018 results, touting the Company's "operational achievements" and its ability "to exceed [its] revenue and EBITDA expectations for 2018." Throughout the relevant period, eHealth continued to reaffirm the Company's strong momentum with reports of increasing enrollment and revenue growth, each time attesting that the reports fairly represented "the financial condition and results of operations of eHealth, Inc." Contrary to eHealth's representations, on April 8, 2020, Muddy Waters Research published a report disclosing "eHealth's highly aggressive accounting masks what we believe is a highly unprofitable business" and that "the key driver of growth since 2018 has been [eHealth's] reliance on Direct Response television advertising, which attracts an unprofitable, high churn enrollee." As a result of its findings, Muddy Waters concluded that "[eHealth] management is, in our view, running a massive stock promotion." On this news, eHealth's stock price fell $12.82, or 12%, to close at $103.20 per share.

eHealth, Inc. (EHTH) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. Click here to receive free alerts from Stock Watch when companies engage in wrongdoing.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:EHTH

Release Versions
$Cashtags

Contacts

Leo Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
lkandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Flotek Industries, Inc. (FTK) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Flotek Industries, Inc. (NYSE: FTK) securities between August 3, 2026 and August 17, 2026 (the "Class Period"). Flotek is an energy technology and services company.The complaint alleges that Flotek misled investors by failing to disclose the cancellation of its $400m Puerto Rican deal.Investors who suffered s...

Robbins LLP Encourages WSE Stockholders with Large Losses to Seek Counsel for the Securities Class Action Lawsuit Against Wise Group plc

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Robbins LLP Urges Investors of ARS Pharmaceuticals Inc. to Contact the Firm for Information About the SPRY Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class Period"). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization of neffy for needle-free intranasal delivery of epinephrine for emergency treatment of Type 1 allergic reactions, incl...
Back to Newsroom